RJA
OGN icon

Ross\Johnson & Associates’s Organon & Co OGN Stock Holding History

Ross\Johnson & Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27 Hold
2
– – ﹤0.01% 359
2026
Q1 		$12 Hold
2
– – ﹤0.01% 215
2025
Q4 		$14 Hold
2
– – ﹤0.01% 353
2025
Q3 		$21 Hold
2
– – ﹤0.01% 213
2025
Q2 		$19 Sell
2
-60
-97% -$619 ﹤0.01% 212
2025
Q1 		$923 Hold
62
– – 0.02% 214
2024
Q4 		$925 Buy
+62
New +$1.01K 0.02% 81

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Ross\Johnson & Associates's OGN Position: Q2 2026 in Review

Ross\Johnson & Associates held its Organon & Co (OGN) position steady in Q2 2026 at 2 shares worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #359.

Ross\Johnson & Associates first reported a position in OGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $925 in Q4 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Ross\Johnson & Associates held 2 shares of Organon & Co worth $27 as of Q2 2026.
  • Ross\Johnson & Associates left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of Ross\Johnson & Associates's portfolio in Q2 2026, its #359 holding.
  • Ross\Johnson & Associates first reported a position in Organon & Co in Q4 2024 and has held it in 7 quarters since.
  • Ross\Johnson & Associates's Organon & Co position peaked at $925 in Q4 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.